Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy

Fig. 5

Expression of VCAM1 and EGFR in healthy vs. tumor tissue based on HPA data. a Representative tissue cores from the HPA showing immunohistochemistry (IHC) staining for VCAM1. Left core, normal kidney; right core, renal cancer. b, c Summarized data for immunoreactive scores (IRS) for normal (pooled n = 6) and tumor kidney (pooled n = 23) from two antibodies shown separately (b) and pooled (c). d Representative tissue cores from the HPA showing IHC staining for EGFR. Left core, normal kidney; right core, renal cancer. e, f Summarized data for IRS for normal (pooled n = 12) and tumor kidney (pooled n = 44) from five antibodies shown separately (e) and pooled (f). In f, antibody CAB068186 which showed opposite results was not included. Scale bars, 200 μm

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us